Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venglustat for pain in Fabry disease
2024-511990-31-00Phase 3Authorised
- Sponsor
- Sanofi
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 22
01
Overview
Phase 3, randomised, double-blind trial in Fabry disease (FD) comparing Venglustat with Placebo (2 arms). Planned start Jun 2022; status: authorised.
02
Drugs
venglustat
03
Conditions
Fabry disease (FD)
Beyond the preview
Go deeper on 2024-511990-31-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511990-31-00.